Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
An Investigator initiated trial (IIT) using a prospective, randomized, double-blind, parallel group, placebo-controlled, clinical study design.
Epistemonikos ID: 94be4e366093a74bb39fe166a0b8ae671678f32f
First added on: May 09, 2024